Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic ovary syndrome (PCOS) affects about 10% of women, is often linked to obesity and family history, and can cause irregular periods, fertility issues, and other symptoms. It's usually managed with lifestyle changes, weight loss, and medication.

Vitamin D helps improve PCOS by aiding insulin function and ovarian health.

Researchers found 24 genes that change significantly and affect cashmere growth in goats; this could help increase cashmere production.

Effective management of PCOS includes lifestyle changes, medication for menstrual regulation, fertility treatments, and cosmetic issue remedies.

Combining ciclosporin and simvastatin can cause severe kidney damage.

A woman developed severe kidney injury from using simvastatin with ciclosporin, highlighting the need for careful monitoring when combining these drugs.

High testosterone increases heart disease risk in women with PCOS.

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

High levels of androgens during early development may cause PCOS-like symptoms.

The conclusion is that metformin is a first-line treatment for PCOS, particularly for restoring ovulation and increasing pregnancy rates, with other treatments depending on specific symptoms.

Ayurvedic treatment helped a woman with PCOS conceive and deliver a healthy baby.

Lifestyle changes like diet and exercise are key for treating overweight women with polycystic ovary syndrome.

The book provides a detailed guide on managing Polycystic Ovary Syndrome and is useful for physicians.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

WNT10A mutations often cause ectodermal dysplasias, with males showing more tooth issues than females.

Chitosan-decorated polymersomes improve finasteride delivery for hair loss treatment.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Boys with less severe EDA mutations in XLHED have milder symptoms and better sweat and hair production.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Future research on ectodysplasin should explore its role in diseases, stem cells, and evolution, and continue developing treatments for genetic disorders like hypohidrotic ectodermal dysplasia.

High levels of TNF-α may contribute to obesity and insulin resistance in PCOS, but not due to the C850T genetic variation.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.

Lifestyle changes are the first step in treating infertility in PCOS, followed by medications like clomiphene and metformin, and then surgery if needed.

PCOS lowers quality of life, causing issues like obesity, infertility, and menstrual problems.

The article concludes that global standardization in PCOS research is crucial for accurate diagnosis and understanding of the condition.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

Low doses of BPA can increase prostate growth and change hormone levels in adult rats.